#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Chronic lymphocytic leukaemia refractory Canavan disease Oesophageal achalasia Methylmalonic acidaemia Adrenoleukodystrophy Pelizaeus-Merzbacher disease Hodgkin's disease Myelin oligodendrocyte glycoprotein antibody-associated disease Palmar-plantar erythrodysaesthesia syndrome IgA nephropathy Non-small cell lung cancer recurrent Hepatic angiosarcoma Cardiac amyloidosis Noonan syndrome More trials…

    Learn about Rare Diseases

    Friedreich’s ataxia – Treatment Propionic acidaemia – Trials in Disease Mitochondrial myopathy – Life with Disease Mucous membrane pemphigoid – Diagnostics Andersen-Tawil syndrome – Diagnostics Langerhans cell sarcoma – Basic Information Prolymphocytic leukaemia – Trials in Disease Alport’s syndrome Ornithine transcarbamoylase deficiency – Life with Disease Indolent systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Capecitabine Xp-Dc+Tl+Klh Caba-201 Ceritinib Istaroxime Elinzanetant Adct-402 Clenbuterol Hydrochloride Tetracaine Hydrochloride Cobimetinib Hydroxyzine Hydrochloride Fludeoxyglucose (18F) ALE.P03 Esomeprazole Magnesium ZAMPILIMAB Linperlisib Nazartinib Ivermectin Neostigmine Methylsulfate Etoricoxib More therapies…

    Learn about Your Condition

    Epstein-Barr virus infection Extra-osseous Ewing's sarcoma Renal failure Anaemia of pregnancy Trigeminal neuralgia Brain neoplasm Nephroblastoma Small intestine carcinoma Kaposi's sarcoma Pulmonary sarcoidosis Actinic keratosis Urticaria chronic Dengue fever Intestinal ischaemia Sleep disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Oesophageal carcinoma

  • Study of Chemoradiation with Carboplatin and Paclitaxel for Elderly Patients with Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Capecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Capecitabine
    The Netherlands

  • Study of Ferumoxtran-10 Enhanced MRI for Detecting Lymph Node Metastases in Patients with Esophageal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • FERUMOXTRAN-10
    The Netherlands

  • Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Pancreatic carcinoma
    • Gastric cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany

  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • AZD4360
    Germany

  • Study of trastuzumab with chemotherapy and immunotherapy combination for first-line treatment in patients with HER2-positive esophageal squamous cell cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Oxaliplatin
    Denmark
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!